T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study

Rakesh Sindhi, Chethan Ashokkumar, Brianna Spishock, Maggie Saunders, Angelo Mabasa, Pradeep Sethi, Ashok Reddy, Bobby Nibhanupudy
doi: https://doi.org/10.1101/2021.05.21.21257442

Article Information

doi 
https://doi.org/10.1101/2021.05.21.21257442
History 
  • May 23, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Rakesh Sindhi, MD1,*,
  2. Chethan Ashokkumar, PhD2,
  3. Brianna Spishock, BS2,
  4. Maggie Saunders2,
  5. Angelo Mabasa, DNP, NP.C3,
  6. Pradeep Sethi, MD2,
  7. Ashok Reddy, BE2 and
  8. Bobby Nibhanupudy, MD4
  1. 1University of Pittsburgh
  2. 2Plexision Inc, Pittsburgh
  3. 3Columbia University Medical Center, NY
  4. 4AdventHealth, Orlando, FL
  1. ↵*Address for correspondence
    : Rakesh Sindhi, MD, University of Pittsburgh, 4401 Penn Avenue, FP6040, Pittsburgh, PA 15224., Email: Rakesh.Sindhi{at}chp.edu, Phone: 412-692-6110
Back to top
Posted May 23, 2021.
Download PDF
Data/Code
Email
T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study
Rakesh Sindhi, Chethan Ashokkumar, Brianna Spishock, Maggie Saunders, Angelo Mabasa, Pradeep Sethi, Ashok Reddy, Bobby Nibhanupudy
medRxiv 2021.05.21.21257442; doi: https://doi.org/10.1101/2021.05.21.21257442
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area